LOGO.jpg
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of Florida
January 28, 2021 09:15 ET | Interpace Biosciences, Inc.
In-network status for ThyGeNEXT® and ThyraMIR® with State’s Largest Payer PARSIPPANY, NJ, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that the...
CocrystalPharmaInc.jpg
Cocrystal Pharma Selects Lead Compound for Further Development Against Coronaviruses
December 22, 2020 08:30 ET | Cocrystal Pharma, Inc.
CDI-45205 holds potential as a therapeutic and as a prophylactic to protect against coronavirus transmission, including SARS-CoV-2 BOTHELL, Wash., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cocrystal...
Teneo_logo_FINAL_whitebkgnd.png
TeneoFour’s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals
November 16, 2020 11:00 ET | TeneoBio, Inc
NEWARK, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Teneobio, Inc. and its affiliate TeneoFour, Inc. announced today a Nature Metabolism publication...
BetterLife Pharma Receives Approval from Altum Pharmaceuticals Inc. Shareholders to Complete Merger
July 30, 2020 07:30 ET | BetterLife Pharma
Vancouver, July 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT), an emerging biotechnology company with proprietary...
BetterLife New Logo.png
BetterLife CEO Discusses Synairgen’s Interferon Breakthrough Treatment
July 28, 2020 08:00 ET | BetterLife Pharma
New York City, July 28, 2020 (GLOBE NEWSWIRE) -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company currently preparing a potential...
BetterLife CEO Discusses Merger, Planned Interferon Treatment Trials and Potential Subsequent FDA Emergency Use Authorization
July 23, 2020 08:00 ET | BetterLife Pharma
New York City, July 23, 2020 (GLOBE NEWSWIRE) -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRD) (CSE:BETR), an emerging biotechnology company currently preparing its own...
Interferon Treatment Trial 'a Major Breakthrough' Against the Pandemic
July 21, 2020 08:00 ET | BetterLife Pharma
NEW YORK CITY, July 21, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (OTCQB:BETRD) (CSE:BETR) has been a strong advocate and defender of using interferons as...
AMR Logo.png
Respiratory Care Devices Market to Reach $21.3billion by 2022 at 7.4% CAGR, Says AMR
July 02, 2020 10:46 ET | Allied Market Research
Portland, OR, July 02, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global respiratory care devices market was valued at $12.89 billion in 2015, and is...
BetterLife Pharma (OTCB:BETRD) CEO Discusses Using Interferons to Defeat ‘Truly Evil Virus’
July 02, 2020 08:00 ET | BDA International
New York City, July 02, 2020 (GLOBE NEWSWIRE) -- The CEO of BetterLife Pharma (OTCQB:BETRD) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, recently...
AMR Logo.png
Topical Pain Relief Market to Reach $13,276 million by 2025 at 7.4% CAGR, Says AMR
June 24, 2020 11:10 ET | Allied Market Research
Portland, OR, June 24, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the topical pain relief market was valued at $7,481 million in 2017, and is expected to...